Nima Alidoust

Nima Alidoust is the CEO and Co-Founder of Vevo Therapeutics, a biotechnology company focused on improving drug discovery using an innovative in vivo drug discovery platform and AI models. Previously, Nima served as the Founding CEO of Good Chemistry Company, a venture that emerged from 1QBit and was acquired for $75 million. Nima's earlier experience includes leadership roles at Rigetti Computing, where responsibilities spanned product management and strategy in quantum computing, and a tenure at McKinsey & Company, providing strategic insights to clients in advanced industries. Nima's academic credentials include a Ph.D. in Computational and Quantum Chemistry from Princeton University, a B.A. in Physics and Classics from Middlebury College, and an International Baccalaureate from Pearson College UWC.